You probably reach for a sweetener without thinking twice. A packet in your coffee, a diet soda with lunch, a protein bar between meetings.
Most of us treat these little swaps as the "safe" option over sugar.
A new laboratory study from the University of Cambridge suggests the picture gets more complicated when certain sweeteners meet certain prescription drugs.
Researchers tested 39 commercial sweeteners against human gut bacteria. One combination stood out. Isosteviol, a compound derived from stevia, mixed with the antidepressant duloxetine (sold as Cymbalta) synergistically suppressed two beneficial gut microbes.
Also read: Long COVID could be raising your blood pressure, study finds
The two bacteria are Roseburia intestinalis and Parabacteroides merdae. Both are helpful residents of a healthy gut.
The findings come from petri dishes and simplified bacterial communities in the lab, not from people. The researchers are explicit that more research is needed before anyone draws clinical conclusions about effects in humans.
Three quarters of sweeteners nudged at least one gut bacterium
The team at the Medical Research Council Toxicology Unit cultured 25 gut bacterial strains and exposed them to the 39 sweeteners. Around three-quarters of the sweeteners changed the growth of at least one bacterial species.
The results were published in Molecular Systems Biology. The team then tested the sweeteners alongside four commonly co-consumed compounds: another sweetener (advantame), caffeine, the flavoring vanillin, and the antidepressant duloxetine.
Also read: Research reveals what happens when you eat too much protein
More than 100 interactions turned up between the sweeteners and those four co-consumed compounds. Some pairings strengthened a sweetener's effect on gut bacteria; others weakened it.
Isosteviol with duloxetine was the strongest signal. Duloxetine is one of the most widely prescribed antidepressants in the United States.
"Sweeteners are often marketed as metabolically neutral, but our study challenges this idea," lead author Dr Sonja Blasche said in a University of Cambridge statement.
Why this sits in a mental health story
Gut bacteria do more than help you digest a meal. They produce short-chain fatty acids, train your immune system and signal the brain through the gut-brain axis.
Also read: This is what happens to your body if you drink chai tea every day
There is already a growing body of research on how everyday artificial sweeteners can shift that community in subtle ways.
Roseburia intestinalis is one of the microbes that makes butyrate, a short-chain fatty acid linked to a calmer, less inflamed gut lining.
When the Cambridge team reconstructed a simplified gut community in the lab and added isosteviol with duloxetine, the mix reduced microbial diversity. A less varied gut community has been associated with poorer digestive health in other research.
What this means if you take duloxetine
The study is not a signal to stop taking an antidepressant. The researchers did not test blood, brains or people. If you take duloxetine or another prescribed antidepressant, keep taking it as prescribed and raise any questions with your doctor before changing anything.
Also read: Beer, wine or spirits? one drink was linked to a surprising health benefit
What the paper does suggest is that "sweetener-safe" is less settled than many of us assume. Sweeteners can interact with other compounds in your diet and medicine cabinet, and the combined effect is not always the sum of the parts.
The Cambridge researchers say human studies on these sweetener-drug interactions are the next step before clinical conclusions can be drawn.
Also read: One extra year in school could change your dementia risk
This article is made and published by Ida-Marie Palm Varbæk, who may have used AI in the preparation.